Suppr超能文献

通过中国新生儿筛查发现肉毒碱棕榈酰转移酶 1A 的新突变:一例病例报告。

Novel mutation in carnitine palmitoyltransferase 1A detected through newborn screening for a presymptomatic case in China: a case report.

机构信息

Pediatric Department, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.

Neonatal Genetic Metabolic Disease Screening and Treatment Center in Hubei Province, Wuhan, People's Republic of China.

出版信息

Ital J Pediatr. 2021 Jul 7;47(1):154. doi: 10.1186/s13052-021-01094-5.

Abstract

BACKGROUND

Carnitine palmitoyltransferase 1A (CPT1A) deficiency is a rare mitochondrial fatty acid oxidation (FAO) disorder that results in hypoketotic hypoglycemia and hepatic encephalopathy. It is caused by mutation in CPT1A. To date, only two symptomatic cases of CPT1A deficiency have been reported in China.

CASE PRESENTATION

A newborn male, without any disease-related clinical manifestations, was diagnosed with CPT1A deficiency through newborn screening. Increased free carnitine levels and a significantly increased C0/(C16 + C18) ratio were detected by tandem mass spectrometry, and subsequently, mutations in CPT1A were found by gene sequence analysis. The patient was advised a low-fat, high-protein diet and followed up regularly. During three-years of follow-up since, the patient showed normal growth velocity and developmental milestones. Whole-exome sequence identified two mutations, c.2201 T > C (p.F734S) and c.1318G > A (p.A440T), in the patient. The c.2201 T > C mutation, which has been reported previously, was inherited from his father, while the c.1318G > A, a novel mutation, was inherited from his mother. The amino acid residues encoded by original sequences are highly conserved across different species. These mutations slightly altered the three-dimensional structure of the protein, as analyzed by molecular modeling, suggesting that they may be pathogenic.

CONCLUSION

This is the first case of CPT1A deficiency detected through newborn screening based on diagnostic levels of free carnitine, in China. Three years follow-up suggested that early diagnosis and diet management may improve the prognosis in CPT1A patient. In addition, we identified a novel mutation c.1318G > A in CPT1A,and a possible unique to Chinese lineage mutation c.2201 T > C. Our findings have expanded the gene spectrum of this rare condition and provided a basis for family genetic counseling and prenatal diagnosis.

摘要

背景

肉碱棕榈酰转移酶 1A(CPT1A)缺乏症是一种罕见的线粒体脂肪酸氧化(FAO)障碍,可导致低酮性低血糖和肝性脑病。它是由 CPT1A 基因突变引起的。迄今为止,中国仅报道了两例有症状的 CPT1A 缺乏症病例。

病例介绍

一名无任何相关疾病临床表现的新生儿,通过新生儿筛查诊断为 CPT1A 缺乏症。串联质谱分析显示游离肉碱水平升高,C0/(C16+C18)比值显著升高,随后通过基因序列分析发现 CPT1A 基因突变。建议患者采用低脂肪、高蛋白饮食,并定期随访。在随后的 3 年随访中,患者生长速度和发育里程碑均正常。全外显子组测序发现患者存在两个突变,c.2201T>C(p.F734S)和 c.1318G>A(p.A440T)。c.2201T>C 突变是从父亲那里遗传的,已经有报道,而 c.1318G>A 是从母亲那里遗传的新突变。原始序列编码的氨基酸残基在不同物种中高度保守。这些突变通过分子建模分析,略微改变了蛋白质的三维结构,提示它们可能是致病性的。

结论

这是中国首例基于游离肉碱诊断水平通过新生儿筛查发现的 CPT1A 缺乏症病例。3 年随访表明,早期诊断和饮食管理可能改善 CPT1A 患者的预后。此外,我们在 CPT1A 中发现了一个新的突变 c.1318G>A,并确定了一个可能为中国特有的突变 c.2201T>C。我们的发现扩大了这种罕见疾病的基因谱,为家族遗传咨询和产前诊断提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5951/8261918/6e9fd9333fdb/13052_2021_1094_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验